It has been reported that mRNA expression level of hTERT is highly correlated with telomerase activity in tumor cells.[3] TERC are targeted by imetelstat sodium (GRN163L), an inhibitor of telomerase activity in cancer therapy.[4] Nevertheless, genetic factors that regulate the variability of gene expression are not well understood. The gene discussed is TERC; the disease is cancer.